BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 18, 2010
View Archived Issues
Correlation between genetic variations in Lp(a) lipoprotein and risk of CAD identified
Read More
Crystal structure of PI3Kdelta in complex with inhibitors allows design of enhanced agents
Read More
Novo Nordisk: 2009 in review
Read More
Rexahn provides update on goals for 2010
Read More
Nippon Shinyaku and Actelion enter into license agreement on novel PAH therapeutic
Read More
Biodegradable nanocarriers with drug delivery and imaging properties described as theranostic agents
Read More
Otonomy receives FDA clearance for trial in Meniere's disease
Read More
Pulmonary blood density measured by MRI may be used in PAH and heart failure prognosis
Read More
Javelin receives FDA PDUFA date for Dyloject NDA for pain
Read More
Ligand reports discovery of dual AT1/ETA receptor antagonists
Read More
Roche presents novel CCR2 antagonists
Read More
Cardiac reserve index differentiates heart failure patients from healthy subjects
Read More
Marcadia Biotech initiates phase I trial of MAR-701
Read More
Genfit reports the identification of novel PPAR agonists
Read More
Georgetown University discloses MLCP inhibitors for cancer therapy
Read More
Merck KGaA discloses novel SphK1 and Met kinase inhibitors
Read More
MorphoSys and Galapagos add another antibody target to alliance in bone and joint diseases
Read More
TD2 and Rondaxe sign alliance to help emerging companies develop cancer therapeutics
Read More
BioMimetic completes submission of PMA to FDA for Augment Bone Graft
Read More
Biogen and Biovitrum restructure collaboration agreement for rFVIIIFc and rFIXFc
Read More
Michael J. Fox Foundation funds research into LRRK2 gene
Read More
Hollis-Eden Pharmaceuticals becomes Harbor BioSciences
Read More
FDA issues complete response letter for GSK's Horizant in RLS
Read More
Pharmasset updates progress of RG-7128 studies
Read More
Pivotal Research adds U.S. center to phase II study of VA-111913 for dysmenorrhea
Read More